This website is intended for UK healthcare professionals only. Not a UK healthcare professional? Click here.
Resources and support
Educational resources and expert opinions
Hear from experts and their opinions on the primary care management of hypercholesterolaemia/mixed dyslipidaemia.
Considerations for CVD risk reduction in patients with diabetes and elevated LDL-C
Join leading experts as they discuss key considerations for managing hypercholesterolaemia and mixed dyslipidaemia in patients with diabetes, with a focus on reducing their heightened CV risk through effective lipid-lowering therapies
Dr. Patrick Holmes and Beverley Bostock
8 mins
Lipid masterclass series – evidence into practice in CVD
In this video, experts discussed the unmet need in CV risk reduction using combination lipid therapy. Learn about the challenges and opportunities in lipid management for your patients as well as insights from clinical studies which can be translated into your clinical practice
13 chapters
Lipid masterclass series – lipid management in diabetes and elevated LDL-C
In this video, leading experts discussed the unmet CV risk reduction needs in patients with diabetes and elevated LDL-C. It covers why combination lipid therapy is important for your eligible patients, evidence supporting NUSTENDI® in reducing CV risk and guidance on applying this evidence in clinical practice
13 chapters
The eligible NILEMDO®/NUSTENDI® patient – who are they?
Discover which patients bempedoic acid (+/- ezetimibe) would be an appropriate therapeutic option
6 mins
Practical resources and information
Patient resources that are only to be shared via HCPs and are not to be shown to patients from this website.
NUSTENDI® Patient Brochure
Downloadable brochure to support patients with their NUSTENDI® treatment
9 mins
NILEMDO® Patient Brochure
Downloadable brochure to support patients with their NILEMDO® treatment
7.30 mins
Access to implementation support and tools
This content is only for use by HCPs in the UK and other appropriate decision-making personnel* that support the management of patient care.
This content should not replace individual clinical judgement or processes that may already be in place. Clinical judgement should be applied when considering the applicability of this content.
*Other relevant decision makers particularly include those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply, or use of any medicine but who are not HCPs.
The logistics of implementing guidance and treatment pathways can be challenging. Daiichi Sankyo UK is pleased to offer personalised support, to help you ensure that eligible patients have access to NILEMDO® or NUSTENDI® when they need it.
Support available:
Formularies and Treatment Pathway Support
Contact the DSUK SBD Regional Access Managers for promotional support in shaping the healthcare ecosystem to enable access to lipid-lowering therapies. This support may include guidance on formulary inclusion, optimising treatment pathways and sharing best practice examples
Education for Pharmacy Professionals
Contact the DSUK SBD Regional Access Managers to arrange promotional educational support for pharmacy professionals in your locality about the clinical and practical implementation of lipid management with NILEMDO® and/or NUSTENDI®
Tools and materials available:
Lipid Implementation Pack
This toolkit offers valuable knowledge and practical strategies for the effective implementation of lipid management. This promotional resource is designed to support HCPs in incorporating lipid-lowering therapies, such as NILEMDO® and NUSTENDI® into clinical practice. Funded and developed by DSUK
Total System Value Pack
This model quantifies the burden of hypercholesterolaemia and mixed dyslipidaemia while demonstrating the holistic benefits of improved lipid management and goal attainment
Further Information
For information on Lipid Management Services offered by Daiichi Sankyo UK please see https://www.daiichi-sankyo.co.uk/about-us/responsibility/donations/ where you can submit a request for support or further information.
Abbreviations
CV, cardiovascular; CVD, cardiovascular disease; DSUK, Daiichi Sankyo UK; HCP, healthcare professional; LDL-C, low-density lipoprotein cholesterol; NHS, National Health Service; SBD, speciality business division; UK, United Kingdom.
Job code: UK/BIL/10/25/0003|Date of preparation: November 2025